曝光臺 注意防騙 網(wǎng)曝天貓店富美金盛家居專營店坑蒙拐騙欺詐消費(fèi)者

Replacement Page Amdt No. 11 – Dsecember 2004 Civil Aviation Safety Authority
Part 67 — 31
3.6 If there is any personal history of problematic use of a substance
(within the meaning given by section 1.1 of Annex 1, Personnel
Licensing, to the Chicago Convention):
(a) the person’s abstinence from problematic use of the substance is
certified by an appropriate specialist medical practitioner; and
(b) the person is not suffering from any safety-relevant sequelae
resulting from the person’s use of the substance; and
(c) the person provides evidence that the person is undertaking, or
has successfully completed, an appropriate course of therapy
Note In Annex 1, Personnel Licensing, to the Chicago Convention,
‘Problematic use of substances’ is defined as follows:
‘The use of one or more psychoactive substances by aviation personnel in a
way that:
a) constitutes a direct hazard to the user or endangers the lives, health or
welfare of others; and/or
b) causes or worsens an occupational, social, mental or physical problem
or disorder.’.
‘Psychoactive substances’ is there defined as ‘Alcohol, opioids, cannabinoids,
sedatives and hypnotics, cocaine, other psychostimulants, hallucinogens, and
volatile solvents, whereas coffee and tobacco are excluded.’.
Nervous system
3.7 Has no established medical history or clinical diagnosis of:
(a) a safety-relevant disease of the nervous system; or
(b) epilepsy; or
(c) a disturbance of consciousness for which there is no satisfactory
medical explanation and which may recur
3.8 Is not suffering from safety-relevant effects of a head injury or
neurosurgical procedure
Cardiovascular system
3.9 Has no safety-relevant heart abnormality
3.10 Systolic and diastolic blood pressures are within limits specified by
CASA from time to time in the Designated Aviation Medical
Examiner’s Handbook (even if approved drugs are used to maintain the
blood pressure within those limits)
3.11 Has no significant functional or structural abnormality of the
circulatory tree
Respiratory system
3.12 Is not suffering from a safety-relevant condition of the respiratory
system
Alimentary system and metabolic disorders
3.13 Is not suffering from a safety-relevant defect of the digestive system or
its adnexae, nor from any safety-relevant effect of disease or trauma of,
or an operation on, the digestive system or its adnexae
3.14 Is not suffering from safety-relevant metabolic, nutritional or endocrine
disorders
Civil Aviation Safety Regulations 1998 (CASR)
CASR – 1st Edition – January 2003 Office of Legal Counsel
Replacement Page Amdt No. 11 – Dsecember 2004 Civil Aviation Safety Authority
Part 67 — 32
3.15 If suffering from diabetes mellitus:
(a) the condition is satisfactorily controlled without the use of any
anti-diabetic drug; or
(b) if an oral anti-diabetic drug is used to control the condition:
(i) the condition is under on-going medical supervision and
control; and
(ii) the oral drug is approved by CASA
Reticulo-endothelial system
3.16 Is not suffering from a safety-relevant condition of any of the following
kinds:
(a) localised or generalised enlargement of the lymphatic nodes;
(b) a disease of the blood;
(c) an immune deficiency disorder
Genito-urinary system
3.17 Is not suffering from any safety relevant disease of the genito-urinary
system
3.18 Has no sequelae of disease or surgical procedures on the kidneys or
urinary tract
3.19 Kidneys and urinary tract are free of significant obstructions
3.20 If there is any personal history of syphilis — provides evidence that
adequate treatment has been completed and that there are no safetyrelevant
sequelae of the infection
Gynaecological and obstetrical
3.21 Does not suffer from safety-relevant menstrual disturbances
3.22 If pregnant — the pregnancy is not likely to interfere with the safe
exercise of privileges, or performance of duties, under the licence held
or applied for
Note See regulation 67.235 regarding the periods during which a pregnant
woman must not exercise the privileges of a licence.
Skeletal system
3.23 Is not suffering from safety-relevant active disease of the bones, joints,
muscles or tendons
3.24 Is not suffering from safety-relevant functional sequelae of medically
significant conditions of the bones, joints, muscles or tendons
Ear, nose and throat
3.25 Is not suffering from:
(a) active pathological processes of the internal ear or of the middle
　
中國航空網(wǎng) www.k6050.com
航空翻譯 www.aviation.cn
本文鏈接地址：澳大利亞CASR Civil Aviation Safety Regulations中(32)